Assured Pharmacy, Inc. - Provides Clarification of Confidential Treatment ('CT') Order Filing on March 10, 2009

Jan 13, 2010, 11:26 ET from Assured Pharmacy, Inc.

FRISCO, Texas, Jan. 13 /PRNewswire-FirstCall/ -- Assured Pharmacy, Inc. (Pink Sheets: APHY), announced today that due to numerous inquiries, the Company would like to provide further clarification on the Confidential Treatment ("CT") Order filing dated March 10, 2009.  The CT Order filing that appears in the Company's public filings available at is an order of the SEC granting the Company's previous request for confidential treatment of certain information that was omitted from a prime vendor agreement that the Company entered into with AmerisourceBergen Drug Corporation, a Delaware corporation, which was filed as an exhibit to the Form 8-K filed on October 9, 2008. The 8-K filing is accessible from the following link:

About Assured Pharmacy, Inc.

Assured Pharmacy, Inc. is engaged in the business of operating specialty pharmacies that primarily dispense highly regulated pain medication. The Company derives its revenue primarily from the sale of prescription drugs and does not keep in inventory non-prescription drugs or health and beauty related products inventoried at traditional pharmacies. The Company offers physicians the ability to electronically transmit prescriptions to its pharmacies. The majority of the Company's business is derived from repeat business from its customers. "Walk-in" prescriptions from physicians are limited. The Company currently has four operating pharmacies. Three of those pharmacies are wholly owned and the Company has a 94.8% ownership interest in the other pharmacy.

Safe Harbor Statement

This document and other written or oral statements made from time to time may contain forward-looking statement s covered by the Private Securities Litigation Reform Act of 1995.  Statements that are not historical in nature and which may be identified by the use of words like "expects," "assumes," "projects," "anticipates," "estimates," "we believe," "target," "could be," and other words of similar meaning, are forward-looking statements.  These statements are based on managements' expectations and assumptions and are subject to risks and uncertainties that may cause actual results by the forward-looking statements  include: lack of sufficient financing for opening new pharmacies, government regulation and controls, and inability to manage growth.  Additional information concerning factors that could cause actual results to differ materially from those projected is contained in the Company's filing with the Securities and Exchange Commission.  The Company undertakes no obligation to revise or update forward-looking statements as a result of new information since these statements may no longer be accurate or timely.

Investor Contact:  

Mr. Robert DelVecchio

Chief Executive Officer

Assured Pharmacy, Inc.

(214) 220-9302

SOURCE Assured Pharmacy, Inc.